Member Info for Porky9

@PM2022
1. So "you have a feeling" 201 will get concluded. Hope your right but don't see it myself. I have said before that THX have no real desire or need to hand over £1.3m to Valirx. Why do that if you don't need to??? Secondly show me ANY IM or Investor prospectus from THX that even indicates what they are trying to raise?. I cant find anything stateside.
Large investors, family offices , II even need more than just "a feeling" and thirdly; lets just say THX had a deal on the brink of being signed, they would be buying shares here like no tomorrow. Don't know about 50 transactions more like 550 -this is going to take much more time if at all but, as i say, VAL should at least moneytise something out of this, get THX to help pay something if only to help reduce reduce cash burn, THX are not even paying anything to the lab fees!!!

2. Barcelona - Hope your right but could still go either way. We don't know if its a success or a flop but even if its a major success it wont result in cash landing short term. SH like you are just hoping for a SP spike for a fast buck. It doesn't work like that.

@HeresHopin
I would back Adam without question, but I'm watching this and reading some of the ridiculous pro ramp posts and PM2022 how its going to be 50p tomorrow and its just ridiculous.

You don't like my post because it doesn't fit with a pro ramp agenda but equally you are trying to drag small time investors into this when its really a long term play and it will need more cash.

Secondly, half the posters are not even reading the house broker report. I refer back to this document because it re-confirms EXACTLY what Suzy said last night. No change there. They are building out a lab network via both organic and acquisition. This is a significant change and risk profile compared to what was backed two years ago :
READ it:- https://www.cenkos.com/research-portal/

@Adam
You know I think you are a terrific guy, I really do but the BOD have really let you and many others down here, it’s outrageous frankly:-

1. You say; 201 is horrific they have been horribly let down. YES, however the BOD are totally culpable. They made this decision Adam, their flagship product in partnership with Cancer Research UK that in the words of George “it bloody works” was given away to a start up without a pot to pee in.

2. The BOD lack ANY commercial acumen frankly. I wont go into the CENKOS deals, the late 10p placing etc and other blunders But it’s the SH base paying for their mistakes. That’s not right. Someone should grasp the nettle and say to THX “ you want exclusivity – if the £1.3m is not with us by X date we want £250k down and £10k a month to maintain it” some kind of financial deal to at least moneytise something from it. You are telling me they cant pay ANYTHING???? If that’s the case its totally the wrong partner, cut loses and start again.

3. They are pushing a build out policy on the labs before they are ready. I would rather see them spend £100k on a sales rep on £40k and two marketing staff on £30k each putting packages together for tCRO work and blitzing the market to get deals/revenue in. Not dreaming about who they can buy with someone else’s money and waltzing around bloody exhibitions at cost. Now is not the time for acquisitions it’s a ruse to boost working capital IMO.

4. You refer to the valuation of SAR but look at the investor base it has: major II holding the SP up. VAL have done nothing with the previous brokers S P Angel or Cenkos to secure II support. Now they are feeding a second mouth with Turner Pope and a PR Firm (don’t go there). They only way that II would get in currently is if they are offered loads of shares at knock down prices to support an acquisition or merger and that might be the plan?

5. You are a top guy and frankly, I don’t want sound patronising, you know what you are doing but if I had your exposure here firstly I wouldn’t increase it further until Stella puts some of her own cash at least £100k at risk. The BOD needs skin in the game and secondly, I would wait to see what the plans are from July H2 – if you don’t like them, raise a resolution to put you on the board, the SH would vote you on the board in a heartbeat.

Frankly, I would Move Suzy to head sciences, she is brilliant at it but not a CEO, review Kevin and Lampshire , what value do they add and review what Mark is doing for his money, “corporate development manager” yet zero new business or revenue in last 10 years – come on.

I know my post is harsh but if the BOD WONT or CANT act in SH interests and start making decent commercial decisions then you probably need to step in and do it for them. Its an absolutely travesty to see a drug such as 201 on the shelf doing nothing it help anyone whilst THX firk about with it at SH expense.

Market Closed
Oh please, the ramping is back off the scale again.
@Lockdowns – you openly admit to trading, your £6k buy yesterday is underwater due to the spread, you are simply pumping this to get your profit to cash out at others expense. Likewise, some other chancers.

Also I guess some just read what they like into the presentation yesterday. Yet Suzy was VERY clear on what she said:-

1. They will need more cash to drive the tCRO forward fact. Suzy has been clear about this. The figures are before you all. Read the numbers.

2. H1 Acquisition. So clearly, they are sticking to a build out policy. My view on this is No No and No again. Investment in the lab is 500k and 300k for three staff; lab manager, assistant and business manager. Make that viable first is my call but they wont hold off, don’t need to.

3. The business plan is now to have stable revenue from the lab to iron out peaks and troughs whilst they try and position the pipeline. A shrewd and sound move frankly BUT it will take time and a lot more cash from shareholders to do this.

4. It look’s very much like to me that they will wrap an acquisition in with working capital raise. I stand by my call AGM 40m shares at 5p and 10m to Investors to raise £2.5m from July. Worse if they need to give more shares away as part of an acquisition.

5. There is NO event that can bring cash in before the end of H1. Language on 201 changed IMO, it went from previously “unconcerned” to now it being a “binary outcome” THX will either get funded or they wont – not “They have an IM out with 20 investors and expecting to see the cash by X” or something equally specific. Looks to me that 201 cash is a long way off if at all.

6. 301 has been in Japan with what feels like a lifetime and no progress yet that can be concluded. Meanwhile missing market opportunity.

7. Barcelona - no confirmation could be a hit or miss but even a hit won’t bring immediate cash in. Likewise, CLX fantastic but NO cash in. They need SH money to advance both of these Lines. It will take time.

8. Did anyone spot that the cycle of a drug chart is now 1-20years and changed from 1-12years which was used two or so presentations back? So, managing investor expectations.

9. Short term, LT SH will get diluted to oblivion for sure. The ramping club wont like me saying that but its reality. Its business.

10. The board are NOT buying IMO simply because they will need to raise, they will likely support that raise at that time and that’s the time to consider this. Bit each to their own

Good Luck all.

@Laura
Don’t be so over protective, it’s an AIM business
We don’t have clarity on the churn rates. I’m assuming with the admin overheads some business was added in the period, yet revenues went down?
That being said, despite these figures I actually like the business and can see from recent appointments they are doing something to drive client wins going forward which is a positive but as with a lot on AIM it’s all jam tomorrow.
Will be interesting to see how the market views this anyhow
Good luck

On pure financials it doesn't read great.
Revenue down 50k on the comparable H1 with admin overheads up by just shy of 120k
and just under £500k of working capital left.
Appreciate that doesn't reflect some of the repositioning and positive work carried out here but even so you would expect stronger performance especially coming out from a covid year.
With the recent buying and positivity i was expecting stronger financial performance
Will be interesting how the market views this
Good Luck

@Iceman888
You don't know the first thing about me or the wins/losses in my investment portfolio - way off the mark, you really are. I don't publish the majority. So please stop trying to second guess me. You also don't know a thing about my charity work. Trawling through past posts to discredit me is also poor show, focus on the stock not its investors.

To insinuate i have issues in my marriage is also an absolute disgrace. I only invest in penny shares what i can afford to lose and my portfolio is varied and is actually in profit despite a hit on Novacyt in the 2021 year and hit on 4D in the 2022 year, so cut it out that's my business and nothing to do with you. IF you have 100% success on every stock you buy i would call you a bloody liar. Its the nature of investing.

I comment here because i have done my homework and followed this stock closely. I have also made a reasonable return on this stock, i am one of the few investors here that has made good money.

You on the other hand hadn't even read the CENKOS broker note yet you ramp this 24/7 here. You don't listen to what the company is telling you, you only hear what you want to hear. This is because you are underwater from 20p and desperate to claw your cash back at any cost.

What you should consider however is that i met a guy recently that lost a big chunk of his pension fund on 4D. The amount was no big deal to me but was to him in relation to his total financial position and he was borderline suicidal over it. I realised that some people can get in over their heads on these penny shares. So when you and PM2022 start pumping this to kingdom come saying the SP will be 7 times higher shortly just think about that. There is a real investment risk here, they can lose the lot, that's the reality.

I have attempted to bring balance to this debate. I will return at the H2 i am not averse to risk but this play is going to take time and I can deploy those funds to better use elsewhere in the short term and revaluate this in July once they set their stall out.

A further placing in July is practically guaranteed IMO, they can't meet the current business plan without one. The only event that can change that is if the £1.3m cash from THX comes in and even that is not enough as i believe they will need to raise a further £2.5m - what is uncertain is the price point of the placing.

Time will tell how events unfold here, good luck to you, we are all investing to make returns but take a moment to reflect.

Take care

Pork's

Its quite because you delete any messages you don't like, its like a full blown ramping club here.

Getting very excited over a power of attorney notice being filed against 201. This was on the 21st Feb. This is an expected part of a very long process.

What's important is when/ if VAL will see the colour of any money from THX. If the cash doesn't land then its SH funding via a placement. Time will tell.

Meanwhile, to be fair they are doing a good ramping job sucking a few more in but its facts that count. cash is king, money in the bank that counts.

good luck anyhow, see what happens.

Thanks Adam- All points noted
They are kind of stuck in this spend and raise cycle. For me I just need that bit more proof of concept and solid stewardess of the company by the board. As I said, not sure all the required skill sets are there but see how it goes.

Also, I guess I just don’t like continual dilution without results on any AIM plays either. Going into H2 a raise needs to have a detailed action plan of how we get towards break even as I see it. Let’s see what they put forward.

Finally, I hear what you say regarding board flexibility v CENKOS report but I read these reports, others in my network including a family office I support also go off these. I couldn’t find an IM or anything at all on THX raise I could pass on, again puts off larger investments and if your saying the CENKOS reports are not reflecting the business this is something to address and could be putting off II.

It would be better for VAL to have one decent broker that understands and helps promote the business to funds than two in it half hearted, one with potentially inaccurate information.

Anyhow, wish you well, the SP got a good boost on Friday hope there is some substance behind it this time. Good luck going forwards. Catch up with you in H2 unless something material happens in the meantime. Take care,

Pork’s

@PM
It’s that sort of blatant ramping that annoys the hell out of me

Something is only worth what someone will pay for it, suggesting she might take any “early deal” shows a certain naivety, Investors want deals with big Pharma at the right sale price, this takes time. They don’t want another THX where it’s given away or a quick cheap deal.Entering into DD with a potential buyer in some cases can take almost a year in this industry. Get real will you.

Suggesting the value of the business should be 7 times higher after a 10p placing at fair value is another example. These things take time.

Please stop taking the Rampacetomol tablets they are not good for you :)

I’m not declaring my business interests on a public forum, I’m just not. I don’t have to prove a thing to you. Frankly, you can think and do what you like, I couldn’t care less

I have given a précis of how I see the situation, you are free to counter any point I have made, it’s all in the public domain. I have also said I will refrain from posting providing the ramping club calm down and want to see the outline business forward plans from H2 July onwards to review and evaluate. I have further said I will consider backing it providing it demonstrates a route to break even.

Can’t say fairer than that

Good day to you and good luck

Hi Adam

Appreciate the reply.

You know I have maximum respect for you as like myself you have built companies from the ground floor up and been on the “coal face” and not had free hand outs, so you totally get it. If you were on the board here it would be a totally different conversation.

I have outlined many of the shortfalls here as you know. You say a Buy and Build isn’t going to happen BUT this is what the current business plan confirms. Until the BOD confirms its ditched, as an investor I have to assume its still the plan.

The BOD have materially let you down as all Shareholders, I do however think the message is loud and clear to them and I hope they do “get it” but with the continuing errors being made, its relentless, I am of the opinion that we need a Board change. Move Suzy to head sciences, that’s her passion and employ a competent CEO such as yourself to drive the commercial side.

Anyhow they have a window to make the changes and prove they can do it.

I’m going to refrain from posting providing the ramping club don’t get out of hand, it upsets too many here that need reassurance even though the whole point of these boards is to discuss. I will chat with you around the end of H1 when they outline the plans from H2 (July onwards). By then I would expect a conclusion on 201 either way, either THX get the cash over or Suzy finally kills off the albatross and agrees to find a new buyer.

I am expecting a placing into H2, I can’t see how it can be avoided and if the plans look good and it’s a FINAL raise towards revenue generation, I will likely back it. Its down to what price it will be at, if they get sustainable rises following the jump on Friday you have a chance north of 10p if not I do see it as going back to April 21 as low as 3.5p level again. We are going to know soon enough.

One final thing, not that you wont know this already, you only need 10% SH support to call a general meeting and also carry out a poll vote of a proposed resolution. So IF when they unveil the forward plans from H2 they are still coming the same nonsense, not addressing the big issues, you could put an alternative plan forward. So either they do it, or its gets done for them. You would secure the support from shareholders for sure.

We can't risk potentially drugs that could make a difference not seeing their true potential due to incompetent management, this has to change for everyone's benefit.

Let’s see how events turn out.

Pork’s

Oh gawd.. Ramping club on the post straight away

Look NOTHING has changed what so ever, the business is the same today as it was on Thursday, all that changed is someone or a couple of people punted some cash on it for a bounce from 9.5p on Friday and it dragged some retail in with it, this event happens every few weeks look at the chart and then drifts back as profits are taken.

Maybe your RNS and update on 201 will land Monday and the buying was as a result of a leak? you can but hope.

Tell you what, i will put my positive pants on for you and wish you all well for next week. See how it goes, lets hope you get that break through but for sustained value its going to take time and more cash as i see it.

Results should be published in about 4-5 weeks time which wont paint a great picture on the financial front but hopefully an update with it, if not before will add positivity regarding progress to drive it forwards.

Good Luck

You won’t get a re-rate without some kind of major event that is cash producing landing, anything else will be a short term bounce.

This was simply a Friday pump by a handful of people buying some blocks of shares and PI buying off the back of it to pump the price. A suckers rally.

You have shares paid to brokers as fees, you have warrant holders ready to cash and sell and you have placing holders desperate to make a profit on their 11p recent holding.

For this SP to move without a sell off there needs to be an event that confirms cash coming in during H1. Ideally confirmation that the £1.3m cash and lab fees is going to land from THX. I hope you get it, it’s gone on long enough.

See what Monday brings, will we get an RNS to that effect or not. Without an event like that a July placement is practically a certain bet. Time will tell.

Hey @ICE
If you get News on some cash landing Monday fair play to you
Still looks like a P&D spike to me but maybe something leaked today you never know.
Acid test will be Monday, if they raise the bid to 11 that could give the 10p/11p placers chance to exit some at profit - lets see.

My Call was :
10p Bid / 11 ASK at close
we got
10.5p Bid / 11.5p Close

So not that far out but agreed i don't think you could have a much better day for the stock, good outcome for you - well done.

Lets see
I'm going to call 10.0 BID/11 ASK at close
Back to 9.5 BID / 10 ASK by close Monday
Far more time required and a Friday P&D just doesn't cut it for me
Seen it worn the T-Shirt
Happy Hunting

@HD
Not a buyer on P&D Friday spikes, this is a regular event on this stock.
Need to see substance behind it
Too many itchy fingers on the sell button for me
See what next week brings
GL
Pork's

@HD
Err nope, stocks don’t move in straight lines
Said all that needs saying, BOD fully aware of position
I’m not a buyer on spikes
But this is great today for SH,
Just need to see the plans from H2
Good luck all

@Sootysnipes
Guy's just venting at me, I have no complaint, i don't take any offence.
Pork rind for skin... lol
Take Care

OK i doff my hat to you @PM2022
Lets give them chance to outline for H2 and go from there.
Not looking for a war, just to explore, comment on events.
Take care Now
Pork's